Literature DB >> 29523675

Chimeric Antigen Receptor T Cell Therapy and the Kidney: What the Nephrologist Needs to Know.

Kenar D Jhaveri1, Mitchell H Rosner2.   

Abstract

Keywords:  CAR-T; adaptive cell transfer; chimeric receptor receptor therapy; cytokines; drug nephrotoxicity; onconephrology

Mesh：

Substances：

Year:  2018        PMID： 29523675      PMCID： PMC5969488          DOI： 10.2215/CJN.12871117

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.

Authors:  David L Porter; Bruce L Levine; Michael Kalos; Adam Bagg; Carl H June
Journal:  N Engl J Med       Date:  2011-08-10       Impact factor: 91.245

Review 2.  Chimeric antigen receptor T cell therapy: 25years in the making.

Authors:  Saar Gill; Marcela V Maus; David L Porter
Journal:  Blood Rev       Date:  2015-11-06       Impact factor: 8.250

3.  Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.

Authors:  Julie C Fitzgerald; Scott L Weiss; Shannon L Maude; David M Barrett; Simon F Lacey; J Joseph Melenhorst; Pamela Shaw; Robert A Berg; Carl H June; David L Porter; Noelle V Frey; Stephan A Grupp; David T Teachey
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

4.  Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors:  Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

Review 5.  Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

Authors:  Sattva S Neelapu; Sudhakar Tummala; Partow Kebriaei; William Wierda; Cristina Gutierrez; Frederick L Locke; Krishna V Komanduri; Yi Lin; Nitin Jain; Naval Daver; Jason Westin; Alison M Gulbis; Monica E Loghin; John F de Groot; Sherry Adkins; Suzanne E Davis; Katayoun Rezvani; Patrick Hwu; Elizabeth J Shpall
Journal:  Nat Rev Clin Oncol       Date:  2017-09-19       Impact factor: 66.675

Review 6.  Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia.

Authors:  Noelle V Frey; David L Porter
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

7.  Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

Authors:  G Gross; T Waks; Z Eshhar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

Authors:  Stephan A Grupp; Michael Kalos; David Barrett; Richard Aplenc; David L Porter; Susan R Rheingold; David T Teachey; Anne Chew; Bernd Hauck; J Fraser Wright; Michael C Milone; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2013-03-25       Impact factor: 91.245

9.  B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma.

Authors:  Robert O Carpenter; Moses O Evbuomwan; Stefania Pittaluga; Jeremy J Rose; Mark Raffeld; Shicheng Yang; Ronald E Gress; Frances T Hakim; James N Kochenderfer
Journal:  Clin Cancer Res       Date:  2013-01-23       Impact factor: 12.531

Review 10.  Toxicity and management in CAR T-cell therapy.

Authors:  Challice L Bonifant; Hollie J Jackson; Renier J Brentjens; Kevin J Curran
Journal:  Mol Ther Oncolytics       Date:  2016-04-20       Impact factor: 7.200
  10 in total
  14 in total

Review 1.  Critical Care Management of Toxicities Associated With Targeted Agents and Immunotherapies for Cancer.

Authors:  Cristina Gutierrez; Colleen McEvoy; Laveena Munshi; R Scott Stephens; Michael E Detsky; Joseph L Nates; Stephen M Pastores
Journal:  Crit Care Med       Date:  2020-01       Impact factor: 7.598

2.  Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma.

Authors:  Shruti Gupta; Harish Seethapathy; Ian A Strohbehn; Matthew J Frigault; Elizabeth K O'Donnell; Caron A Jacobson; Shveta S Motwani; Samir M Parikh; Gary C Curhan; Kerry L Reynolds; David E Leaf; Meghan E Sise
Journal:  Am J Kidney Dis       Date:  2020-01-20       Impact factor: 8.860

Review 3.  Kidney injury and disease in patients with haematological malignancies.

Authors:  Frank Bridoux; Paul Cockwell; Ilya Glezerman; Victoria Gutgarts; Jonathan J Hogan; Kenar D Jhaveri; Florent Joly; Samih H Nasr; Deirdre Sawinski; Nelson Leung
Journal:  Nat Rev Nephrol       Date:  2021-03-30       Impact factor: 28.314

Review 4.  Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells.

Authors:  Haneen Shalabi; Juliane Gust; Agne Taraseviciute; Pamela L Wolters; Allison B Leahy; Carlos Sandi; Theodore W Laetsch; Lori Wiener; Rebecca A Gardner; Veronique Nussenblatt; Joshua A Hill; Kevin J Curran; Timothy S Olson; Colleen Annesley; Hao-Wei Wang; Javed Khan; Marcelo C Pasquini; Christine N Duncan; Stephan A Grupp; Michael A Pulsipher; Nirali N Shah
Journal:  Nat Rev Clin Oncol       Date:  2021-01-25       Impact factor: 66.675

Review 5.  Electrolyte and Acid-Base Disorders Associated with Cancer Immunotherapy.

Authors:  Nupur N Uppal; Biruh T Workeneh; Helbert Rondon-Berrios; Kenar D Jhaveri
Journal:  Clin J Am Soc Nephrol       Date:  2022-01-21       Impact factor: 10.614

Review 6.  A Review of Cancer Immunotherapy Toxicity II: Adoptive Cellular Therapies, Kinase Inhibitors, Monoclonal Antibodies, and Oncolytic Viruses.

Authors:  Neeraj Chhabra; Joseph Kennedy
Journal:  J Med Toxicol       Date:  2021-04-05

7.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events.

Authors:  Marcela V Maus; Sara Alexander; Michael R Bishop; Jennifer N Brudno; Colleen Callahan; Marco L Davila; Claudia Diamonte; Jorg Dietrich; Julie C Fitzgerald; Matthew J Frigault; Terry J Fry; Jennifer L Holter-Chakrabarty; Krishna V Komanduri; Daniel W Lee; Frederick L Locke; Shannon L Maude; Philip L McCarthy; Elena Mead; Sattva S Neelapu; Tomas G Neilan; Bianca D Santomasso; Elizabeth J Shpall; David T Teachey; Cameron J Turtle; Tom Whitehead; Stephan A Grupp
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

8.  Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery.

Authors:  Victoria Gutgarts; Tania Jain; Junting Zheng; Molly A Maloy; Josel D Ruiz; Martina Pennisi; Edgar A Jaimes; Miguel-Angel Perales; Jaffer Sathick
Journal:  Biol Blood Marrow Transplant       Date:  2020-02-20       Impact factor: 5.742

9.  Incidence of death from kidney diseases among cancer patients: a US population-based analysis.

Authors:  Xiaoli Li; Wenhui Chen; Jinfang Feng; Bo Zhao
Journal:  Int Urol Nephrol       Date:  2021-03-08       Impact factor: 2.370

10.  Perspectives From an Onconephrology Interest Group: Conference Report.

Authors:  Abhijat Kitchlu; Christopher T Chan; Nelson Leung; Sheldon Chen; Sheron Latcha; Paul Tam
Journal:  Can J Kidney Health Dis       Date:  2020-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.